HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Zacks Rank    Equity Research    Premium Home    My Account    Help    
A Better Way to Make Money in Today's Market
Learn more now >>
Quote:
Login Free Membership
Search:

 
Analyst Blog  

CHINA Looking to Rise Up

November 11, 2008 | Comments: 0
Recommended this article (1)
Print    Share

With a strong track record in consolidation and organic growth of its software business, we believe CDC Corporation (CHINA - Snapshot Report) is poised for growth. With continuous focus on vertical industries and cost reduction initiatives in its software segment, CDC should develop a significant competitive advantage in this year and beyond.

New launches and upgrades (Yulgang 2.0 and Ross Enterprise v6.3) in its product line as well as its share repurchase plan currently in action will further help the company drive growth. As such, we maintain our Buy rating on the shares of CDC with a six-month target price of $3.50.

We remain encouraged by the growing potential of CDC's two primary business units - CDC Software and CDC Games. The Software business is the most important business segment for CDC, which is growing organically and through acquisitions, and is currently building momentum in its strategic vertical industries. CDC is a leading global provider of enterprise software solutions and services to medium and large enterprises.

Anita Mohata contributed to this report.

Read the full analyst report on CHINA


Email

Print

Share

RSS

Rate Pos

Rate Neg

Comment
Read/Post Comments (0) | Recommended this article (1)
 Posting Comment...
There was a problem posting this this comment. Please try back later.
[CLICK TO CLOSE X]
Comments (Limit 1000 Characters - Used: 0)
Display Name: Email Address:  
 Loading Comments...
Be the first to comment on this article!

More Zacks Resources

Market Summary Nov 08, 2009 07:12 am ET
DJIA 10023.42  17.46 0.17%
NASD 2112.44  7.12 0.34%
S&P 500 1069.3  2.67 0.25%
Sponsored Links